SymBio PharmaceuticalsCompany research
Click on headlines below to download research
Supply issues continue
SymBio Pharmaceuticals | 21/02/2020
SymBio reported sales of $25.8m (¥2.838bn) for 2019 and an operating loss of $39.1 (¥4.301bn). Sales were down from 2018 due to the previously…
Supply issues continue
SymBio Pharmaceuticals | 21/02/2020
SymBio reported sales of ¥2.838bn for 2019 and an operating loss of ¥4.301bn. Sales were down from 2018 due to the previously announced quality…
Treakisym has positive DLBCL results
SymBio Pharmaceuticals | 05/12/2019
On 5 November 2019, SymBio announced it obtained positive results in its pivotal Phase III clinical trial of Treakisym (bendamustine) in patients with…